Abstract:Diabetic cardiomyopathy (DCM) is a chronic complication of diabetes mellitus, characterized by abnormalities of myocardial structure and function. Researches on the models of type 1 and type 2 diabetes mellitus as well as the application of genetic engineering technology help in understanding the molecular mechanism of DCM. DCM has multiple hallmarks, including hyperglycemia, insulin resistance, increased free radical production, lipid peroxidation, mitochondrial dysfunction, endothelial dysfunction, and cell death. Essentially, cell death is considered to be the terminal pathway of cardiomyocytes during DCM. Morphologically, cell death can be classified into four different forms: apoptosis, autophagy, necrosis, and entosis. Apoptosis, as type I cell death, is the fastest form of cell death and mainly occurs depending on the caspase proteolytic cascade. Autophagy, as type II cell death, is a degradation process to remove damaged proteins, dysfunctional organelles and commences by the formation of autophagosome. Necrosis is type III cell death, which contains a great diversity of cell death processes, such as necroptosis and pyroptosis. Entosis is type IV cell death, displaying "cell-in-cell" cytological features and requires the engulfing cells to execute. There are also some other types of cell death such as ferroptosis, parthanatos, netotic cell death, lysosomal dependent cell death, alkaliptosis or oxeiptosis, which are possibly involved in DCM. Drugs or compounds targeting the signals involved in cell death have been used in clinics or experiments to treat DCM. This review briefly summarizes the mechanisms and implications of cell death in DCM, which is beneficial to improve the understanding of cell death in DCM and may propose novel and ideal strategies in future.

Regulated cell death pathways in cardiomyopathy

Downregulation Of Cypher Induces Apoptosis In Cardiomyocytes Via Akt/P38 Mapk Signaling Pathway

Programmed death of cardiomyocytes in cardiovascular disease and new therapeutic approaches

Programmed Necrosis in Cardiomyocytes: Mitochondria, Death Receptors and Beyond.

Ferroptosis, necroptosis and cuproptosis: Novel forms of regulated cell death in diabetic cardiomyopathy

Diabetic Cardiomyopathy and Cell Death: Focus on Metal-Mediated Cell Death

Regulated cell death in myocardial ischemia-reperfusion injury

Programmed Cell Death: Complex Regulatory Networks in Cardiovascular Disease

Regulated cell death in acute myocardial infarction: Molecular mechanisms and therapeutic implications

Molecular Mechanisms of Cardiomyocyte Death in Drug-Induced Cardiotoxicity

Cell death regulation in myocardial toxicity induced by antineoplastic drugs

Cardiomyocyte death in sepsis: Mechanisms and regulation (Review)

Epigenetic Regulation of Diverse Regulated Cell Death Modalities in Cardiovascular Disease:Insights into Necroptosis, Pyroptosis, Ferroptosis, and Cuproptosis

Distinct Types of Cell Death and the Implication in Diabetic Cardiomyopathy

Programmed Necrosis in Heart Disease: Molecular Mechanisms and Clinical Implications.

Cell death and diabetic cardiomyopathy

Small Molecules, Big Effects: the Role of Micrornas in Regulation of Cardiomyocyte Death

Regulated vascular smooth muscle cell death in vascular diseases

CaMKII in Regulation of Cell Death During Myocardial Reperfusion Injury

Mechanisms and Therapeutic Potential of Multiple Forms of Cell Death in Myocardial Ischemia–Reperfusion Injury

Pyroptosis and Its Regulation in Diabetic Cardiomyopathy